General Information of the Compound
| Compound ID |
CP0405046
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(1H-1,3-benzodiazol-2-yl)quinoxaline
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-(1H-Benzoimidazole-2-yl)quinoxaline
2-(1H-benzimidazol-2-yl)quinoxaline
2-(1H-benzo[d]imidazol-2-yl)quinoxaline
BDBM21215
CHEMBL200636
benzimidazole-quinoxaline, C1
benzimidazolylquinoxaline
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H10N4
|
||||||||||||||||||
| Molecular Weight |
246.273
|
||||||||||||||||||
| Canonical SMILES |
c1ccc2[nH]c(nc2c1)-c1cnc2ccccc2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H10N4/c1-2-6-11-10(5-1)16-9-14(17-11)15-18-12-7-3-4-8-13(12)19-15/h1-9H,(H,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
AYFBMQMYJRNGIM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01279, Adenosine receptor A3
Clinical Information about the Compound